Aspergillus antigen chimeric receptors and use thereof

ALTERNATIVE INTRACELLULAR SIGNALLING DOMAIN OF A CHIMERIC ANTIGEN RECEPTOR

Method for continuous production of recombinant GLP-1 peptide by bacteria

Recombinant lubricins, and compositions and methods for using the same

PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE

UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY

ENPP1 Polypeptides and Methods of Using Same

SIRP1α targeted chimeric proteins and uses thereof

CAGED-DEGRON-BASED MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME

Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof

ANTIBODIES SPECIFIC TO HUMAN NECTIN-2

Variant ICOS ligand immunomodulatory proteins and related compositions and methods

Immune cell compositions and methods of use

Nucleic acid construct

GLUCURONOXYLOMANNAN (GXM) RECEPTOR CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF

REDUCING CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS

Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43

Chimeric engulfment receptor molecules

Compositions and methods of phospholipase A2 receptor chimeric autoantibody receptor T cells

HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS

ANTIBODY-TUMOR NECROSIS FACTOR alpha FUSION PROTEIN AND ITS PREPARATION AND APPLICATIONS

RECOMBINANT MILK PROTEINS

PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS

Unstructured non-repetitive polypeptides having lcst behavior

Chimeric antigen receptor (CAR) modulation

METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT

Anti-Abeta Antibodies

Tandem Protein Expression

Claudin18.2 binding moieties and uses thereof

FUSION PROTEIN OF ANTIBODY THAT RECOGNIZES CANCER CELLS AND MUTANT STREPTAVIDIN

CD133-BINDING AGENTS AND USES THEREOF

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Expression of novel cell tags

HIGHLY MODULAR BIEPITOPIC AND BISPECIFIC CAR-T CELLS FOR CANCER IMMUNOTHERAPY

Cross species single domain antibodies targeting mesothelin for treating solid tumors

Drug regulated transgene expression

Multifunctional protein

Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof

Human application of engineered chimeric antigen receptor (CAR) T-cells

PSCA CAR-T CELLS

Lym-1 and Lym-2 antibody compositions and improved car constructs

D-domain containing polypeptides and uses thereof

AAV-EPO FOR TREATING COMPANION ANIMALS

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

Anti-Abeta Antibodies

Antibodies specific to CD44

Engineered immune cells targeting BCMA and their uses thereof

MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS

ANTIBODIES SPECIFIC TO MUC18

BAFF-R antibodies and uses thereof

Anti-Abeta antibodies

Anti-Abeta antibodies

Anti-abeta antibodies

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

REGULATABLE CELL SURFACE RECEPTORS AND RELATED COMPOSITIONS AND METHODS

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist

Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

Composition comprising recombinant GPlbα receptor protein

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

METHODS AND COMPOSITONS FOR MODULATIONS OF IMMUNE RESPONSE

Chimeric T cell receptors, nucleic acids, and methods of making and using the same

IL-15-based fusions to IL-7 and IL-21

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer

BACTERIAL EXPRESSION VECTOR FOR ENHANCED PROTEIN SECRETION

CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER-FAMILY RECEPTORS

Humanized BCMA antibody and BCMA-CAR-T cells

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

EXPOSED COLLAGEN-TARGETED FUSION CYTOKINE FOR IMMUNE MODULATION IN INVASIVE CANCERS AND LESIONS OF INFECTIONS

Universal donor cells

BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

CELL LINES EXPRESSING INSERTED SECRETABLE REPORTER GENES AT MULTIPLE STAGES OF DIFFERENTIATION

ENDOSPORE DISPLAY PLATFORMS, PRODUCTS AND METHODS

Constructs for chimeric antigen receptors

Genetically modified natural killer cells for CD70-directed cancer immunotherapy

CHIMERIC ANTIGEN RECEPTOR AND ITS USE

FIBRONECTIN BINDING DOMAIN CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

SURROGATE CO-RECEPTORS FOR T CELLS AND METHODS OF USE

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

RNA ENCODING A PROTEIN

Method of solubilizing TDP-43 protein aggregates in amyotrophic lateral sclerosis using a microvascular endothelial cell expressing an anti-TDP-43 Fab

Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

CRISPR-Cas12J effector polypeptides and methods of use thereof

CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY

BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof

Oncolytic virus expressing PD-1 binding protein and application of oncolytic virus

METHODS AND COMPOSITIONS TO INDUCE OR SUPPRESS IMMUNE RESPONSES THROUGH THE USE OF MEMBRANE BOUND COMPLEMENT SPLIT PRODUCTS

D-domain containing polypeptides and uses thereof

ROBO1 CAR-NK CELL CARRYING SUICIDE GENE, PREPARATION METHOD AND APPLICATION THEREOF

D-domain containing polypeptides and uses thereof

PRIMARY CELL GENE EDITING

Chimeric polypeptides and methods of altering the membrane localization of the same

CD6 targeted chimeric antigen receptors for treatment of certain autoimmune disorders

MINI-NUCLEOSOME CORE PROTEINS AND USE IN NUCLEIC ACID DELIVERY

METHODS FOR TREATMENT USING CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN

NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION

PHI-4 POLYPEPTIDES AND METHODS FOR THEIR USE

SPHINGOSINE KINASE 1 AND FUSION PROTEIN COMPRISING THE SAME AND USE THEREOF

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

CHIMERIC SIGNAL PEPTIDES FOR PROTEIN PRODUCTION

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Subcutaneous Delivery of Adenovirus with Dual Targeting

METHOD OF MAKING RECOMBINANT SILK AND SILK-AMYLOID HYBRID PROTEINS USING BACTERIA

Chimeric antigen receptor specific for interleukin-23 receptor

Anti-PD-L1 antibodies

Binders of TGFβ-superfamily ligands and uses thereof

Extracellular vesicles comprising engineered fusion proteins

Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

Modified T cells and uses thereof

Chimeric antigen receptors targeting glypican-3 or mesothelin

Chimeric antigen receptors with mutated CD28 phosphorylation sites

Immunocytes expressing a chimeric antigen receptor binding to cancer cells and TNF-related apoptosis-inducing ligand (trail)

Artificial synapses

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

Chimeric antigen receptor with a spacer comprising C2-set Ig-like domains

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

Universal donor cells

Compositions and methods for reducing progression of nephrolithiasis

BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES

GENETICALLY ENGINEERED CAR T CELLS THAT SECRET INTERLEUKIN-12 AND THERAPEUTIC USES THEREOF

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

GAMMA DELTA T CELLS AND USES THEREOF

Use of anti-CD5 antibody drug conjugate (ADC) in allogeneic cell therapy

COMPOSITIONS AND METHODS FOR DETECTING AND REGULATING FIBRONECTIN-INTEGRIN INTERACTION AND SIGNALING

Molecules for organelle-specific protein delivery

Immunogenic composition and use thereof

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

Epcam antibody and Epcam-CAR-T cells

Reducing immune inhibition induced by SIGLEC-15

MESOTHELIN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND T CELLS EXPRESSING SAME

Fc-epsilon car

COMPOSITIONS AND METHODS OF USE OF IL-10 AGENTS IN CONJUNCTION WITH CHIMERIC ANTIGEN RECEPTOR CELL THERAPY

SARS-COV-2 antigen polypeptide, recombinant adeno-associated virus expressing the polypeptide, and vaccine containing the virus

METHODS OF TREATING CANCER WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF

Rapamycin resistant cells

Nucleic acid for treating mite allergy

High affinity B7-H6 antibodies and antibody fragments

Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same

CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF

GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE

Granulysin, method of obtaining same, and uses

CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8 AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS

Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity

Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof

Compositions and methods of treating cancer with chimeric antigen receptors

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors

CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF

Expression of novel cell tags

CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND ENCODING POLYNUCLEOTIDES

CLL1-TARGETING ANTIBODY AND APPLICATION THEREOF

Methods and compositions comprising B7H3 chimeric antigen receptors

Affinity matured CD22-specific monoclonal antibody and uses thereof

Chimeric antigen receptors and methods of making

STABLE MODULATORS OF GAMMA-C-CYTOKINE ACTIVITY

Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains

CRISPR-Cas effector polypeptides and methods of use thereof

Modified cells comprising CRISPR systems

METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING LYMPHOCYTES IN BLOOD OR IN ENRICHED PBMCS

UNIVERSAL CHIMERIC RECEPTORS

NR2F6 INHIBITED CHIMERIC ANTIGEN RECEPTOR CELLS

Activatable cytokine constructs and related compositions and methods

Vaccines against zika virus

Antibodies to MUC16 and methods of use thereof

GD2-based chimeric antigen receptor and application thereof

Recombinant cell surface markers

Chimeric antigen receptor

REDIRECTED CELLS WITH MHC CHIMERIC RECEPTORS AND METHODS OF USE IN IMMUNOTHERAPY

TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors

Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein

CRISPR-Cas effector polypeptides and methods of use thereof

NPP1 FUSION PROTEINS

Delivery of NRF2 as therapy for protection against reactive oxygen species

Compositions and methods for transient gene therapy with enhanced stability

ENGINEERED PHAGOCYTIC RECEPTOR COMPOSITIONS AND METHODS OF USE THEREOF

CHIMERIC ANTIGEN RECEPTORS

ENHANCED PRODUCTION OF IMMUNOGLOBULINS

ANTIBODIES SPECIFIC TO FOLATE RECEPTOR ALPHA

ENGINEERED DNASE ENZYMES AND USE IN THERAPY

Development of recombinant chicken IgY monoclonal antibody and scFv antibodies raised against human tymidine kinase 1 expressed in mammalian cells and use thereof

Anti-PSMA antibodies and use thereof

BCMA-CAR-natural killer (NK) cells and methods related thereto

Single-domain antibodies against CLL1 and constructs thereof

CAR BASED IMMUNOTHERAPY

TRANSFORMING GROWTH FACTOR-BETA-RESPONSIVE POLYPEPTIDES AND THEIR METHODS FOR USE

Methods and compositions for increasing red blood cells

Polypeptides modulating SIGLEC dependent immune responses

Single-domain antibodies against CD33 and constructs thereof

CO-RECEPTOR SYSTEMS FOR TREATING INFECTIOUS DISEASES

Immune cell compositions and methods of use for treating viral and other infections

GENETICALLY-MODIFIED POULTRY EGG

Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVS) for delivery to the GI-tract

CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19

Methods and compositions for treating cancer

ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA

CHIMERIC ANTIGEN RECEPTORS BASED ON SINGLE-DOMAIN ANTIBODIES AND METHODS OF USE THEREOF

CD79A chimeric antigen receptors

CHIMERIC RECEPTORS IN COMBINATION WITH TRANS METABOLISM MOLECULES ENHANCING GLUCOSE IMPORT AND THERAPEUTIC USES THEREOF

Bispecific T cell engager and uses thereof

INHIBITORS OF P-TEFB MEDIATED TRANSCRIPTION

ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF

Compositions and Methods for Retrieving Tumor-related Antibodies and Antigens

Universal T cells and the method of use thereof

BIVALENT CHIMERIC ENGULFMENT RECEPTORS AND USES THEREOF

De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same

Adoptive cellular therapy

Materials and methods for engineering cells and uses thereof in immuno-oncology

MODIFIED GAMMA DELTA T CELLS AND USES THEREOF

Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof

Methods and compositions for treating cancer

EphA3 directed CAR-T cells for treatment of tumors

Receptors for ligand-dependent transcriptional regulation

Inverted transporter polypeptides and methods of using

CHIMERIC ANTIGEN RECEPTOR TUMOR INFILTRATING LYMPHOCYTES

CRISPR-Cas effector polypeptides and methods of use thereof

Therapeutic targeting of non-cellular structures

CHIMERIC HLA ACCESSORY RECEPTOR

Peptide suppressing binding of CTLA4 to B7 proteins, and use thereof

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

VECTOR FOR CO-EXPRESSING GENES OF INTEREST

Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors

TARGETED ENGINEERED INTERFERON AND USES THEREOF

Antibody targeting CLDN18.2, bispecific antibody, ADC, and CAR, and applications thereof

Compositions and methods for producing high secreted yields of recombinant proteins

MODIFIED UROKINASE-TYPE PLASMINOGEN ACTIVATOR POLYPEPTIDES AND METHODS OF USE

BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

IL13Rα2 binding agents and use thereof

Chimeric antigen receptor and application thereof

OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS AND GENE EDITING OF CD2 FOR IMMUNOTHERAPY OF T-CELL MALIGNANCIES

CLDN 18.2-specific monoclonal antibodies and methods of use thereof

IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF

IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

CAR-CD30 T cells for treatment of CD30+ tumors

Compositions and methods for treating HIV/AIDS with immunotherapy

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

NOVEL NUCLEIC ACID MOLECULES

FC-EPSILON CAR (Very imp commercially - in clinical trial)

Fusion protein comprising a Pab1 element and an eIF4G element and use of the fusion protein for improving protein synthesis

Inducible Cell Receptors for Cell-Based Therapeutics

CELL

ADAPTER-BASED RETROVIRAL VECTOR SYSTEM FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same

Calcium-chelating peptides derived from EF-hand calcium-binding motif

NOVEL MAMMALIAN EXPRESSED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEIN ANTIGENS

ENGINEERED CELLS & METHODS

CAR T-CELLS FOR THE TREATMENT OF BONE METASTATIC CANCER

Self-Assembling Multi-Domain Peptide Based Hydrogels

Viral vectors encoding cancer/testis antigens for use in a method of prevention or treatment of cancer

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR?EXPRESSING CELLS

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

CS1 targeted chimeric antigen receptor-modified T cells

EXTRACELLULAR VESICLES DERIVED FROM RECOMBINANT MICROORGANISM INCLUDING POLYNUCLEOTIDE ENCODING TARGET PROTEIN AND USE THEREOF

Modified bacteria and uses thereof

NUCLEIC ACID FOR TREATING MITE ALLERGY

IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

Chimeric antigen receptors targeting BCMA and methods of use thereof

PD-L1 BINDING AFFIMERS, AND USES RELATED THERETO

SYNTHETIC SIGNALING CONSTRUCTS AND ITS USE

NUCLEIC ACID FOR TREATING CRUSTACEAN ALLERGY

NOVEL SYSTEMS FOR SCREENING INTERNALIZING ANTIBODY AND USES THEREOF

Gene therapy constructs and methods of use

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

Mouse having a humanized cluster of differentiation 47 gene

Bakers's yeast expressing anti-staling/freshness amylases

MONOCLONAL ANTIBODY TARGETING A UNIQUE SIALOGLYCOSYLATED CANCER-ASSOCIATED EPITOPE OF CD43

Humanized BCMA antibody and BCMA-CAR-T cells

ANTIBODY-MODIFIED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELL AND USES THEREOF

CELL

Viral vectors and packaging cell lines

Heat-stable metagenomic carbonic anhydrases and their use

Humanized DR4 antibody gene having apoptosis-inducing activity and dual-acting chimeric antigen receptor T cell or natural killer cell therapeutic agent using same

METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION

METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE

Fusion constructs as protein over-expression vectors

Nucleases and methods for making and using them

Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection

PASylated VEGFR/PDGFR fusion proteins and their use in therapy

PROSTATE-SPECIFIC MEMBRANE ANTIGEN CARS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR CHIMERIC LIGAND RECEPTOR (CLR)-MEDIATED CONDITIONAL GENE EXPRESSION

Compositions and methods for treating cancer with anti-CD123 immunotherapy

PD-L2 variant immunomodulatory proteins and uses thereof

Phenotypic markers for cell therapy and related methods

HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer

Modified TCR and uses thereof

Vaccines for human papilloma virus and methods for using the same

Methods for preparing modified von Willebrand Factor

SEPARATION MOIETIES AND METHODS OF USE THEREOF